🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/10/2004 13,32 13,50 12,90 12,96 +0,00% 4,50% 4.150
13/10/2004 13,20 13,62 12,90 12,96 -1,37% 5,45% 10.967
12/10/2004 12,96 13,50 12,90 13,14 -0,90% 4,63% 11.000
11/10/2004 13,32 13,50 12,72 13,26 +2,31% 5,86% 10.533
08/10/2004 13,92 14,22 12,60 12,96 -6,90% 11,64% 33.083
07/10/2004 14,22 14,64 13,20 13,92 +0,00% 10,13% 40.100
06/10/2004 12,48 14,40 12,48 13,92 +7,91% 15,38% 50.267
05/10/2004 12,60 13,20 12,42 12,90 +1,42% 6,19% 9.633
04/10/2004 12,84 12,84 12,30 12,72 +2,91% 4,21% 22.250
01/10/2004 12,30 12,78 12,30 12,36 +0,49% 3,90% 17.900
30/09/2004 13,14 13,14 12,18 12,30 -2,38% 7,31% 15.383
29/09/2004 12,60 12,90 12,06 12,60 +0,48% 6,67% 16.983
28/09/2004 12,60 12,60 12,00 12,54 +0,97% 4,76% 17.350
27/09/2004 12,42 12,66 11,88 12,42 +0,98% 6,28% 26.667
24/09/2004 13,08 13,56 12,30 12,30 -6,82% 9,63% 25.400
23/09/2004 13,02 13,74 12,66 13,20 -1,35% 8,29% 15.117
22/09/2004 13,56 14,28 12,90 13,38 -3,04% 10,18% 17.583
21/09/2004 13,26 14,10 13,02 13,80 +2,22% 8,14% 33.683
20/09/2004 13,92 14,40 13,32 13,50 -5,46% 7,76% 23.767
17/09/2004 14,40 14,64 13,80 14,28 -0,83% 5,83% 16.233
16/09/2004 14,46 15,06 14,34 14,40 -1,64% 4,98% 14.183
15/09/2004 14,10 15,06 14,10 14,64 +1,67% 6,81% 34.033
14/09/2004 14,46 15,00 14,10 14,40 +1,69% 6,22% 37.083
13/09/2004 13,62 14,70 13,26 14,16 +5,36% 10,57% 31.017
10/09/2004 13,50 13,68 13,20 13,44 +0,00% 3,56% 19.300
09/09/2004 13,74 14,40 12,96 13,44 -3,45% 10,48% 39.717
08/09/2004 14,46 14,70 13,80 13,92 -3,73% 6,22% 21.100
07/09/2004 15,60 15,66 13,92 14,46 -6,95% 11,15% 34.783
03/09/2004 15,36 15,96 15,12 15,54 +0,39% 5,47% 15.133
02/09/2004 15,48 15,48 15,12 15,48 -0,39% 2,33% 11.000